Mellanox Technologies (MLNX) Tops Q4 EPS by 12c, Revenues Beat; Provides Q1 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Mellanox Technologies (MLNX) PT Raised to $105 at Susquehanna
January 31, 2019 8:33 AM ESTSusquehanna analyst Christopher Rolland raised the price target on Mellanox Technologies (NASDAQ: MLNX) to $105.00 (from $95.00) while maintaining a Positive rating.
Rolland commented, "Despite the digestion of Ethernet inventory by hyperscalers (portended by INTC and NVDA), InfiniBand growth drove better results/guidance, rare this EPS season."
... More
Pre-Open Stock Movers 01/30: (AMD) (MLNX) (OSK) (BA) (AAPL) Higher; (ACIU) (TUP) (JNPR) Lower (more...)
January 30, 2019 9:21 AM ESTToday's Pre-Open Movers
Co-Diagnostics (NASDAQ: CODX) 168.5% HIGHER; announced today the sale of $3 million of preferred shares, convertible to common stock at a fixed price of $1.20 per share. The transaction consisted of negotiating the conversion of a $2M note to preferred stock, effectively eliminating the Companys debt, and an additional sale of $1M of preferred shares for cash.
AC Immune SA (NASDAQ: ACIU) 51.5% LOWER; announced today that Roche, the parent company of its collaboration partner, is discontinuing the CREAD 1 and... More
Intel (INTC) Offered up to $6 Billion for Mellanox (MLNX) - Calcalist
January 30, 2019 6:18 AM ESTIntel (NASDAQ: INTC) is preparing to buy Mellanox Technologies (NASDAQ: MLNX), according to Calcalist, and bid as much as $6 billion. At least one other competing bid was submitted for the company.
Intel's offer includes cash and shares.
... MoreIntel offered up to $6 billion for Israel's Mellanox: reports
January 30, 2019 2:26 AM ESTTEL AVIV (Reuters) - U.S. chipmaker Intel Corp has bid $5.5-$6 billion in cash and stock to buy Israel's Mellanox Technologies, Israeli media reported on Wednesday.
A $6 billion offer would represent a 35 percent premium to the last closing price of Mellanox on Nasdaq, the Calcalist financial news website... More
Jefferies Reiterates Buy on Mellanox Technologies (MLNX)
January 29, 2019 7:02 AM ESTJefferies analyst, George Notter, reiterated a Buy rating and $130.00 price target on Mellanox Technologies (NASDAQ: MLNX) following growing concerns over the risk of decelerating Data Center spending trends across the industry.
Notter believes that investors should keep their "eyes on the prize"... More

